Company: LIMN
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001104659-25-055078
Chunk: 28

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 28
---
 and Related Stockholder Matters

On May 1, 2025, the ParentCo
Common Stock began trading on The Nasdaq Global Market under the symbol “LIMN” and the ParentCo Public Warrants began trading
on The Nasdaq Capital Market under the symbol “LIMNW.” The Company has not paid any cash dividends on its common stock to
date.

As of May 1, 2025, there
were 12 holders of record of ParentCo Common Stock and two holders of record of ParentCo Public Warrants.

<div align='center'>17</div>

The Board, in its sole discretion,
will make any determination from time to time with respect to the use of any excess cash accumulated, which may include, among other uses,
the payment of dividends on the ParentCo Common Stock. It is not contemplated that the Company will pay cash dividends for the foreseeable
future.

Recent Sales of Unregistered Securities

Information about unregistered
sales of the Company’s equity securities is set forth under Item 3.02 of this Report, which is incorporated herein by reference.

Description of Registrant’s Securities to be Registered

The description of the Company’s
securities is contained in the Proxy Statement/Prospectus in the section titled “Description of ParentCo Capital Stock”
beginning on page 214 of the Proxy Statement/Prospectus, which is incorporated herein by reference.

The Company has 501,000,000
shares of authorized capital stock, which consist of: (i) 500,000,000 shares of common stock, par value $0.0001 per share, and (ii) 1,000,000
shares of preferred stock, par value $0.0001 per share. The outstanding shares of ParentCo Common Stock are fully paid and non-assessable.
As of the Closing Date, there were outstanding 26,014,633 shares of ParentCo Common Stock, after giving effect to the redemptions by Iris
public stockholders in connection with the Business Combination, no shares of the Company’s preferred stock, public warrants to
purchase 6,900,000 shares of ParentCo Common Stock, and private warrants to purchase 835,555 shares of ParentCo Common Stock. Company
stockholders who hold their shares in electronic format in U.S. brokerage accounts are not deemed to be separate stockholders, as such
shares are held of record by Cede & Co., which is counted by the Company’s transfer agent as a single stock